Reaction Details Report a problem with these data
Target
Kallikrein-14
Ligand
BDBM33437
Substrate
n/a
Meas. Tech.
ChEMBL_973067 (CHEMBL2412648)
pH
8±n/a
IC50
>30000±n/a nM
Comments
extracted
Citation
 Tan, X; Furio, L; Reboud-Ravaux, M; Villoutreix, BO; Hovnanian, A; El Amri, C 1,2,4-Triazole derivatives as transient inactivators of kallikreins involved in skin diseases. Bioorg Med Chem Lett 23:4547-51 (2013) [PubMed]  Article 
Target
Name:
Kallikrein-14
Synonyms:
KLK-L6 | KLK14 | KLK14_HUMAN | KLKL6 | Kallikrein 14 | Kallikrein-14 | Kallikrein-like protein 6 | hK14
Type:
PROTEIN
Mol. Mass.:
29136.99
Organism:
Homo sapiens (Human)
Description:
ChEMBL_1282452
Residue:
267
Sequence:
MSLRVLGSGTWPSAPKMFLLLTALQVLAIAMTQSQEDENKIIGGHTCTRSSQPWQAALLAGPRRRFLCGGALLSGQWVITAAHCGRPILQVALGKHNLRRWEATQQVLRVVRQVTHPNYNSRTHDNDLMLLQLQQPARIGRAVRPIEVTQACASPGTSCRVSGWGTISSPIARYPASLQCVNINISPDEVCQKAYPRTITPGMVCAGVPQGGKDSCQGDSGGPLVCRGQLQGLVSWGMERCALPGYPGVYTNLCKYRSWIEETMRDK
  
Inhibitor
Name:
BDBM33437
Synonyms:
(5-amino-3-phenyl-1,2,4-triazol-1-yl)-(3,4-dimethoxyphenyl)methanone | (5-azanyl-3-phenyl-1,2,4-triazol-1-yl)-(3,4-dimethoxyphenyl)methanone | 1-(3,4-dimethoxybenzoyl)-3-phenyl-1H-1,2,4-triazol-5-amine | MLS000099650 | SMR000074479 | cid_975107
Type:
Small organic molecule
Emp. Form.:
C17H16N4O3
Mol. Mass.:
324.3339
SMILES:
COc1ccc(cc1OC)C(=O)n1nc(nc1N)-c1ccccc1
Structure:
Search PDB for entries with ligand similarity: